Canada markets open in 7 hours 3 minutes

Sight Sciences, Inc. (SGHT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.62-0.02 (-0.35%)
At close: 04:00PM EDT
5.62 0.00 (0.00%)
After hours: 04:02PM EDT

Sight Sciences, Inc.

4040 Campbell Avenue
Suite 100
Menlo Park, CA 94025
United States
877 266 1144
https://www.sightsciences.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees214

Key Executives

NameTitlePayExercisedYear Born
Mr. Paul BadawiCo-Founder, President, CEO & Director920.3kN/A1975
Dr. David Badawi M.D.Founder, CTO & DirectorN/AN/A1970
Mr. Sam Boong ParkChief Operating Officer531.78kN/A1961
Ms. Alison Perry BauerleinCFO & TreasurerN/AN/A1981
Mr. Jeremy B. HaydenChief Legal OfficerN/AN/A1970
Mr. Steve R. Tamayo Jr.VP and Chief Ethics & Compliance OfficerN/AN/AN/A
Dr. Reay H. BrownChief Medical OfficerN/AN/AN/A
Tom HuangHead of Corporate Strategy & DevelopmentN/AN/AN/A
Mr. Matthew W. LinkChief Commercial OfficerN/AN/A1975
Mr. Stephen B. Thau J.D.SecretaryN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

Corporate Governance

Sight Sciences, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 9. The pillar scores are Audit: 9; Board: 5; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.